Ostendorf T - Search Results

1

R-roscovitine (CYC202) alleviates renal cell proliferation in nephritis without aggravating podocyte injury.

Milovanceva-Popovska M, Kunter U, Ostendorf T, Petermann A, Rong S, Eitner F, Kerjaschki D, Barnett A, Floege J. Milovanceva-Popovska M, et al. Among authors: ostendorf t. Kidney Int. 2005 Apr;67(4):1362-70. doi: 10.1111/j.1523-1755.2005.00213.x. Kidney Int. 2005. PMID: 15780088 Free article.

2

Cytokines and glomerular injury.

Ostendorf T, Burg M, Floege J. Ostendorf T, et al. Kidney Blood Press Res. 1996;19(5):281-9. doi: 10.1159/000174088. Kidney Blood Press Res. 1996. PMID: 8956240 Review.

3

Role of interleukin-6 in mediating mesangial cell proliferation and matrix production in vivo.

Eitner F, Westerhuis R, Burg M, Weinhold B, Gröne HJ, Ostendorf T, Rüther U, Koch KM, Rees AJ, Floege J. Eitner F, et al. Among authors: ostendorf t. Kidney Int. 1997 Jan;51(1):69-78. doi: 10.1038/ki.1997.9. Kidney Int. 1997. PMID: 8995719 Free article.

4

Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety.

Burg M, Ostendorf T, Mooney A, Koch KM, Floege J. Burg M, et al. Among authors: ostendorf t. Lab Invest. 1997 Apr;76(4):505-16. Lab Invest. 1997. PMID: 9111513

5

Gene-polymorphisms of angiotensin converting enzyme and endothelial nitric oxide synthase in patients with primary glomerulonephritis.

Burg M, Menne J, Ostendorf T, Kliem V, Floege J. Burg M, et al. Among authors: ostendorf t. Clin Nephrol. 1997 Oct;48(4):205-11. Clin Nephrol. 1997. PMID: 9352153

6

C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo.

Canaan-Kühl S, Ostendorf T, Zander K, Koch KM, Floege J. Canaan-Kühl S, et al. Among authors: ostendorf t. Kidney Int. 1998 May;53(5):1143-51. doi: 10.1046/j.1523-1755.1998.00895.x. Kidney Int. 1998. PMID: 9573528 Free article.

7

Improved survival and amelioration of nephrotoxic nephritis in intercellular adhesion molecule-1 knockout mice.

Janssen U, Ostendorf T, Gaertner S, Eitner F, Hedrich HJ, Assmann KJ, Floege J. Janssen U, et al. Among authors: ostendorf t. J Am Soc Nephrol. 1998 Oct;9(10):1805-14. doi: 10.1681/ASN.V9101805. J Am Soc Nephrol. 1998. PMID: 9773781

8

Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers.

Floege J, Ostendorf T, Janssen U, Burg M, Radeke HH, Vargeese C, Gill SC, Green LS, Janjić N. Floege J, et al. Among authors: ostendorf t. Am J Pathol. 1999 Jan;154(1):169-79. doi: 10.1016/S0002-9440(10)65263-7. Am J Pathol. 1999. PMID: 9916931 Free PMC article.

9

[Aptamers: a novel approach to intervention studies and development of novel therapeutic approaches].

Ostendorf T, Floege J. Ostendorf T, et al. Med Klin (Munich). 1999 Apr 15;94(4):219-23. doi: 10.1007/BF03044858. Med Klin (Munich). 1999. PMID: 10373758 Review. German.

10

Aptamers: novel tools for specific intervention studies.

Floege J, Ostendorf T, Janjić N. Floege J, et al. Among authors: ostendorf t. Nephrol Dial Transplant. 1999 Jun;14(6):1354-7. doi: 10.1093/ndt/14.6.1354. Nephrol Dial Transplant. 1999. PMID: 10382991 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters